Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 3 |
2022 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A Review of Pharmacologic Management in the Treatment of Mesothelioma.
Curr Treat Options Oncol. 2021 Jan 12;22(2):14. doi: 10.1007/s11864-020-00807-y.
Curr Treat Options Oncol. 2021.
PMID: 33438079
Review.
Five Year Analysis Assessing the Trend in Prescribing and Expenditures of Oral Oncolytics for Medicare Part D: 2013-2017.
Borrelli EP, McGladrigan CG.
Borrelli EP, et al. Among authors: mcgladrigan cg.
J Pharm Pract. 2022 Aug;35(4):580-586. doi: 10.1177/08971900211000208. Epub 2021 Mar 15.
J Pharm Pract. 2022.
PMID: 33722080
Item in Clipboard
Differences in safety profiles of newly approved medications for multiple myeloma in real-world settings versus randomized controlled trials.
Borrelli EP, McGladrigan CG.
Borrelli EP, et al. Among authors: mcgladrigan cg.
J Oncol Pharm Pract. 2021 Jun;27(4):887-896. doi: 10.1177/1078155220941937. Epub 2020 Jul 19.
J Oncol Pharm Pract. 2021.
PMID: 32686617
Item in Clipboard
Real-world evidence of poly ADP-ribose polymerase inhibitors in the treatment of ovarian cancer: A systematic literature review.
Borrelli EP, McGladrigan CG.
Borrelli EP, et al. Among authors: mcgladrigan cg.
J Oncol Pharm Pract. 2020 Dec;26(8):1977-1986. doi: 10.1177/1078155220940043. Epub 2020 Jul 12.
J Oncol Pharm Pract. 2020.
PMID: 32659172
Item in Clipboard
Cite
Cite